In breast cancer elevated FANCI expression was associated with increased proliferation, while FANCI inhibition has also been shown to sensitize breast cancer cells to the PARP inhibitor in the absence of BRCA mutations [35]. This evidence concerns the gene FANCI and breast carcinoma.